For the quarter ending 2026-03-31, NVAX has $1,043,162K in assets. $1,187,924K in debts. $228,363K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 228,363 | 240,634 | 268,023 | 253,744 |
| Marketable securities | 561,969 | 494,450 | 494,871 | 358,560 |
| Restricted cash | 0 | 10,876 | 10,816 | 10,749 |
| Accounts receivable | 23,312 | 106,446 | 34,174 | 226,396 |
| Inventory | 11,458 | 11,545 | 13,511 | 10,240 |
| Prepaid expenses and other current assets | 25,714 | 26,815 | 45,532 | 59,823 |
| Assets held for sale | 0 | 87,510 | 107,663 | - |
| Total current assets | 850,816 | 978,276 | 974,590 | 919,512 |
| Property and equipment, net | 42,149 | 44,800 | 49,120 | 129,643 |
| Right-of-use asset, net | 21,358 | 22,897 | 23,873 | 153,044 |
| Goodwill | 112,888 | 113,462 | 113,080 | 112,958 |
| Other non-current assets | 15,951 | 17,077 | 19,226 | 21,392 |
| Total assets | 1,043,162 | 1,176,512 | 1,179,889 | 1,336,549 |
| Accounts payable | 16,101 | 24,578 | 15,227 | 50,595 |
| Accrued expenses | 103,027 | 107,165 | 115,586 | 86,697 |
| Deferred revenue | 88,772 | 140,053 | 104,251 | 113,763 |
| Current portion of finance lease liabilities | 2,112 | 2,507 | 5,036 | 5,552 |
| Convertible notes payable | - | 244,213 | 243,835 | 170,568 |
| Other current liabilities | 132,449 | 137,778 | 138,334 | 132,531 |
| Liabilities held for sale | 0 | 47,869 | 51,435 | - |
| Total current liabilities | 342,461 | 459,950 | 429,869 | 389,138 |
| Deferred revenue | 359,273 | 358,943 | 397,105 | 399,263 |
| Long-term debt | 291,039 | - | - | - |
| Non-current finance lease liabilities | 1,907 | 2,091 | 2,269 | 52,370 |
| Other non-current liabilities | 193,244 | 239,068 | 263,483 | 287,585 |
| Total liabilities | 1,187,924 | 1,304,265 | 1,336,561 | 1,298,924 |
| Common stock, 0.01 par value, 600,000,000 shares authorized at march31, 2026 and december31, 2025 167,765,721 shares issued and 164,422,575 shares outstanding at march31, 2026 and 164,969,773 shares issued and 162,575,937 shares outstanding at december31, 2025 | 1,678 | 1,650 | 1,648 | 1,645 |
| Additional paid-in capital | 4,548,592 | 4,539,756 | 4,531,763 | 4,522,193 |
| Accumulated deficit | -4,577,639 | -4,568,148 | -4,585,675 | -4,383,296 |
| Treasury stock, cost basis, 3,343,146 shares at march31, 2026 and 2,393,836 shares at december31, 2025 | 112,319 | 103,021 | 102,663 | 102,459 |
| Accumulated other comprehensive income (loss) | -5,074 | 2,010 | -1,745 | -458 |
| Total stockholders deficit | -144,762 | -127,753 | -156,672 | 37,625 |
| Total liabilities and stockholders deficit | 1,043,162 | 1,176,512 | 1,179,889 | 1,336,549 |
NOVAVAX INC (NVAX)
NOVAVAX INC (NVAX)